Jay Geary
Family Medicine · Tulsa, OKNPI 1821071036
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 355 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,893 and has fallen 99.0% since, to $19 in 2023.
Across 355 payments — averaging $14.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$737
- Lilly USA, LLC$604
- AbbVie$597
- AstraZeneca$428
- Boehringer Ingelheim$376
- Takeda Pharmaceuticals U.S.A., Inc.$285
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,104100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 57 | $737 |
| Lilly USA, LLC | 44 | $604 |
| AbbVie(2 entities) | 54 | $597 |
| AstraZeneca | 29 | $428 |
| Boehringer Ingelheim | 24 | $376 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $285 |
| GSK | 21 | $260 |
| Kowa Pharmaceuticals America, Inc. | 18 | $257 |
| Amgen | 10 | $182 |
| Arbor Pharmaceuticals, Inc. | 8 | $124 |
| Eisai Inc. | 7 | $124 |
| Currax Pharmaceuticals LLC | 9 | $124 |
| Johnson & Johnson | 7 | $101 |
| Mylan Specialty L.p. | 4 | $85 |
| Amarin Pharma, Inc. | 5 | $83 |
| Merck | 6 | $82 |
| Pfizer | 5 | $75 |
| Jazz Pharmaceuticals Inc. | 4 | $72 |
| Bayer | 4 | $64 |
| Abbott | 1 | $63 |
| Teva Pharmaceuticals USA, Inc. | 4 | $57 |
| Shire North American Group Inc | 3 | $54 |
| Biohaven Pharmaceuticals, Inc. | 3 | $49 |
| Genentech USA, Inc. | 3 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| Vertiflex, Inc. | 1 | $33 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Almatica Pharma LLC | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $12 |
| Inogen, Inc. | 1 | $11 |
How this compares
$5,104 in reported general payments places this provider in the 85th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Tulsa
- Geoffrey PlumleeTulsa$297K
- Kimberly HuttonTulsa$76K
- Sarah HallTulsa$52K
- Candy TingTulsa$28K
- Scott GhereTulsa$27K
- Michael MaddoxTulsa$24K
- Randall HerbelTulsa$23K
- Chandan LadTulsa$22K
- Scott SexterTulsa$21K
- Scott KochTulsa$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.